Kristen Kelley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kristen Kelley has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Cole Beeler
Indiana University School of Medicine, Indianapolis, IN
3 shared publications Douglas Webb
Infection Prevention, Indiana University Health, Indianapolis, Indiana, USA
2 shared publicationsLana Dbeibo
Indiana University School of Medicine, Indianapolis, Ind
2 shared publications- Lana Dbeibo
Indiana University School of Medicine
2 shared publications Terrie Beeson
Indiana University Health, Indianapolis, Ind
2 shared publications- Alyson Keen
Indiana University Purdue University at Indianapolis
1 shared publication
Latest Publications
- 25 March 2024
- Published by Elsevier in American Journal of Infection Control
- Vol. 52 (8) , 878-883
Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic
- 25 March 2024
- Published by Elsevier in American Journal of Infection Control
- Vol. 52 (8) , 878-883
Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic
- 1 April 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (4) , 396-399
Real world utilization of nurse-driven urinary catheter removal protocol in patients with epidural pain catheters
- 1 April 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (4) , 396-399
Real world utilization of nurse-driven urinary catheter removal protocol in patients with epidural pain catheters
- Open Access
- 2 February 2021
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 43 (4) , 546-548
Assessment of a universal preprocedural screening program for coronavirus disease 2019 (COVID-19)
Objectives Study objectives were to: (1) Determine the value of a COVID-19 universal preprocedural screening program; and (2) Using the results of asymptomatic positive screens, determine the safety of resuming elective procedures. Design This was a descriptive study detailing the process and findings from implementation of a COVID-19 universal preprocedural screening program. Setting An adult academic tertiary center in Indiana. Patients Patients were included in the analysis if they were screened 96 hours prior to or within 24 hours after undergoing a procedure in the operating room, cardiac catheterization lab, or endoscopy. Methods A report was generated from the electronic health record of patients undergoing procedures from a six week period of time (May 4th-June 14th, 2020). Health records for positive screens were reviewed and classified as symptomatic if they met either criteria: (1) screen performed due to presence of COVID-19 symptoms; (2) documentation of symptoms at the time of the screen. Patients with a positive screen that did not meet symptomatic criteria were classified as asymptomatic. Descriptive statistics were used to calculate frequencies and percentages for the included sample. Results The initial sample included 2,194 patients, comprised of 46 positive and 2,148 negative screens. Out of the 46 patients who had a positive test, 17 were asymptomatic, resulting in an asymptomatic rate of 0.79% (17/2165). Conclusion Findings validated the value of the program through identification of a low rate of asymptomatic positive screens and procedural team adoption and sustainment. Findings may help inform decision making of like organizations attempting to enhance safety while resuming elective procedures.
- 2 February 2021
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 43 (4) , 546-548
Open AccessAssessment of a universal preprocedural screening program for coronavirus disease 2019 (COVID-19)
Objectives Study objectives were to: (1) Determine the value of a COVID-19 universal preprocedural screening program; and (2) Using the results of asymptomatic positive screens, determine the safety of resuming elective procedures. Design This was a descriptive study detailing the process and findings from implementation of a COVID-19 universal preprocedural screening program. Setting An adult academic tertiary center in Indiana. Patients Patients were included in the analysis if they were screened 96 hours prior to or within 24 hours after undergoing a procedure in the operating room, cardiac catheterization lab, or endoscopy. Methods A report was generated from the electronic health record of patients undergoing procedures from a six week period of time (May 4th-June 14th, 2020). Health records for positive screens were reviewed and classified as symptomatic if they met either criteria: (1) screen performed due to presence of COVID-19 symptoms; (2) documentation of symptoms at the time of the screen. Patients with a positive screen that did not meet symptomatic criteria were classified as asymptomatic. Descriptive statistics were used to calculate frequencies and percentages for the included sample. Results The initial sample included 2,194 patients, comprised of 46 positive and 2,148 negative screens. Out of the 46 patients who had a positive test, 17 were asymptomatic, resulting in an asymptomatic rate of 0.79% (17/2165). Conclusion Findings validated the value of the program through identification of a low rate of asymptomatic positive screens and procedural team adoption and sustainment. Findings may help inform decision making of like organizations attempting to enhance safety while resuming elective procedures.
- 1 November 2020
- Published by Elsevier in American Journal of Infection Control
- Vol. 48 (11) , 1375-1380
Changing the culture of urine culturing: Utilizing Agile Implementation to improve diagnostic stewardship in the ICU
- 1 November 2020
- Published by Elsevier in American Journal of Infection Control
- Vol. 48 (11) , 1375-1380
Changing the culture of urine culturing: Utilizing Agile Implementation to improve diagnostic stewardship in the ICU